14 DAY TRIAL // Azyxxi is the brain child of Craig Feied, M.D., Mark Smith, M.D. and Fidrik Iskandar and the technology was completely built using Microsoft exclusive development tools. In mid 2006, Microsoft announced that it was acquiring Azyxxi and subsequently created a division led by Peter Neupert, corporate vice president of the health solutions group and directly subordinate to Craig Mundie, the company's chief research and strategy officer. With Azyxxi, the Redmond company aims at delivering information technology to the healthcare industry. In this sense, Microsoft announced a new partnership with the H. Lee Moffitt Cancer Center & Research Institute involving its unified health enterprise platform.
"After searching for two years, we selected Azyxxi because we believe it provides the healthcare and research context that other products in the marketplace just don't offer," said Ed Martinez, chief information officer at Moffitt. "As a product developed by physicians, Azyxxi works the way clinicians and researchers work. It provides rapid results with minimum clicks, and allows for specific queries to help analyze and visualize data."
"Azyxxi's ability to correlate information and present it in a cohesive way can help any health organization tackle almost any challenge, and this is another great example of that," said Peter Neupert, corporate vice president of the Health Solutions Group at Microsoft Corp. "We are thrilled that Moffitt recognizes Azyxxi as a tool that can help its researchers, clinicians - and ultimately patients - not only in the Moffitt Cancer Center but across the state of Florida."
At the H. Lee Moffitt Cancer Center & Research Institute, Azyxxi will be implemented in the creation of personalized cancer treatment programs. Microsoft stressed the fact that the unified health enterprise platform will provide streamlined access to information; of course, initially the technology will have to swallow all the data the Cancer Center & Research Institute will serve it from magnetic resonance imaging scans, dynamic angiograms, ultrasound images to electrocardiograms and genomic information.